DSM-Firmenich AG (DSFIR) AI Stock Analysis

• Market Cap: €18.95B
• Dividend Yield: 3.48%
• Average Volume (3M): 612.24K
• Price to Earnings (P/E): 26.4
• Beta (1Y): 0.78
• Revenue Growth: 4.46%
• EPS Growth: N/A
• Country: NL
• Employees: 26,301
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Household & Personal Products
• EPS (TTM): 0.89
• Shares Outstanding: 265,676,400
• 10 Day Avg. Volume: 1,008,523
• 30 Day Avg. Volume: 612,240
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €101.73
• Price Target Upside: 41.72% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 11

• Rating: 60 Neutral
• Price Target: €85.00 ▲(18.42% Upside)

DSM-Firmenich AG's overall stock score is primarily driven by its solid financial performance, which indicates strong cash flow and profitability improvements. However, technical analysis shows bearish signals, and the high P/E ratio suggests potential overvaluation. The absence of earnings call and corporate event insights limits additional context.

DSM-Firmenich AG Business Overview & Revenue Model

Company Description

DSM-Firmenich AG (DSFIR) is a leading global innovator in nutrition, health, and sustainable living. Formed through the merger of DSM, a science-based company in nutrition, health, and sustainable living, and Firmenich, a renowned fragrance and flavor company, the conglomerate operates in sectors including food and beverages, personal care, and health. DSM-Firmenich is committed to leveraging scientific expertise to create sustainable and innovative solutions that enhance the quality of life for consumers worldwide.

How the Company Makes Money

DSM-Firmenich AG generates revenue through a diversified portfolio of products and services across its key segments. The company earns money by supplying essential ingredients and solutions to the food and beverage industry, including vitamins, nutritional supplements, and specialty food ingredients. It also produces fragrances and flavors for the personal care and household sectors. Additionally, DSM-Firmenich is involved in health and biosciences, providing solutions for medical nutrition and dietary supplements. Strategic partnerships and a strong focus on research and development also play crucial roles in driving the company's growth and profitability.

DSM-Firmenich AG Financial Statement Overview

Summary

DSM-Firmenich AG shows a positive trajectory with solid revenue growth and improved profitability metrics. The company's balance sheet is stable with manageable debt levels, and its cash flow generation remains strong, supporting ongoing investments and operations.

Income Statement

DSM-Firmenich AG has demonstrated strong revenue growth, with a CAGR of approximately 9% over the last five years. The gross profit margin stands at 33.2%, indicating efficient cost management. However, the company experienced a negative EBIT in 2023, impacting its EBIT margin. Net profit margin improved significantly to 1.95% in 2024 after a substantial loss in 2023, reflecting recovery efforts and operational improvements.

Balance Sheet

The balance sheet is robust with a strong equity base, evidenced by an equity ratio of 66.7% for 2024. The debt-to-equity ratio is moderate at 0.23, indicating prudent leverage use. Return on equity improved to 1.1% in 2024, showcasing an upward trajectory after earlier challenges. However, high total liabilities highlight a need for ongoing debt management.

Cash Flow

Cash flow from operations is solid, with a notable increase in free cash flow in 2024, growing by 71.8% from 2023. The operating cash flow to net income ratio is strong at 7.11, indicating robust cash generation relative to net profits. The free cash flow to net income ratio is favorable at 4.06, reflecting efficient capital expenditure management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	12.46B	12.80B	10.63B	8.39B	11.44B	8.11B
Gross Profit	3.39B	4.25B	2.61B	2.78B	4.19B	2.78B
EBITDA	978.50M	561.00M	822.00M	1.31B	859.00M	1.21B
Net Income	-190.00M	250.00M	-652.00M	460.00M	872.00M	448.00M
Balance Sheet
Total Assets	32.81B	33.75B	34.27B	17.61B	16.02B	14.35B
Cash, Cash Equivalents and Short-Term Investments	1.09B	2.72B	2.56B	2.88B	2.05B	914.00M
Total Debt	4.58B	5.28B	4.83B	3.06B	3.05B	3.54B
Total Liabilities	10.52B	11.05B	11.20B	6.71B	6.62B	6.86B
Stockholders Equity	22.12B	22.51B	22.91B	10.74B	9.32B	7.40B
Cash Flow
Free Cash Flow	753.00M	1.01B	590.00M	279.00M	994.00M	1.04B
Operating Cash Flow	1.45B	1.78B	1.26B	923.00M	1.43B	1.49B
Investing Cash Flow	-571.00M	-252.00M	-795.00M	871.00M	208.00M	-1.48B
Financing Cash Flow	-2.83B	-1.33B	-820.00M	-598.00M	-984.00M	83.00M

DSM-Firmenich AG Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 71.78
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:DSFIR, the sentiment is Negative. The current price of 71.78 is below the 20-day moving average (MA) of 78.19, below the 50-day MA of 81.86, and below the 200-day MA of 90.87, indicating a bearish trend. The MACD of -3.04 indicates Positive momentum. The RSI at 21.77 is Positive, neither overbought nor oversold. The STOCH value of 8.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NL:DSFIR.

DSM-Firmenich AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
APAM	70 Outperform	€2.02B	10.68	6.89%	6.78%	-0.46%	182.29%
MT	68 Neutral	€25.82B	10.53	4.59%	1.43%	-5.35%	―
AMG	66 Neutral	€865.06M	97.48	1.81%	0.69%	5.17%	―
AKZA	65 Neutral	€10.32B	24.84	9.95%	3.28%	-1.57%	-29.52%
DSFIR	60 Neutral	€18.95B	26.36	―	3.48%	4.46%	―
OCI	46 Neutral	€843.18M	-4.14	222.01%	71.01%	―	―
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%